ResearchIn-Press PreviewClinical ResearchOncology
Open Access |
10.1172/jci.insight.201872
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Chen, Z. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by
Sayar, E.
in:
PubMed
|
Google Scholar
|
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Guevara, D. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Richards, H. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Zhang, H. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Patel, R. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Gawne, A. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Liu, L. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Coleman, I. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by
Dumpit, R.
in:
PubMed
|
Google Scholar
|
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Morrissey, C. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Schweizer, M. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Raychaudhuri, R. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Graham, L. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Yu, E. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by
Cheng, H.
in:
PubMed
|
Google Scholar
|
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Ding, C. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by
Wang, Y.
in:
PubMed
|
Google Scholar
|
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Choyke, P. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Turkbey, B. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Chanel-Vos, C. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Fedorov, C. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Otilano III, J. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Kane, T. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Manohar, J. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by
Sigouros, M.
in:
PubMed
|
Google Scholar
|
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Nauseef, J. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Molina, A. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Nanus, D. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by
Tagawa, S.
in:
PubMed
|
Google Scholar
|
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by
Mosquera, J.
in:
PubMed
|
Google Scholar
|
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by
Beltran, H.
in:
PubMed
|
Google Scholar
|
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Etzioni, R. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Nelson, P. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Soundararajan, R. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by
Aparicio, A.
in:
PubMed
|
Google Scholar
|
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Sternberg, C. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Haffner, M. in: PubMed | Google Scholar
1National Cancer Institute, NIH, Bethesda, United States of America
2Fred Hutchinson Cancer Center, Seattle, United States of America
3Englander Institute for Precision Medicine and Weill Cornell Medicine, New York, United States of America
4University of Washington, Seattle, United States of America
5UCSF, San Francisco, United States of America
6University of British Columbia, Vancouver, Canada
7The University of Texas MD Anderson Cancer Center, Houston, United States of America
Find articles by Harmon, S. in: PubMed | Google Scholar
Published August 6, 2026 - More info
Metastatic prostate cancer is a clinically and molecularly heterogeneous disease. Under the selective pressure of androgen receptor (AR)–directed therapies, resistant phenotypes frequently emerge, posing significant diagnostic and therapeutic challenges. Neuroendocrine prostate cancer (NEPC) is a clinically important phenotype characterized by lineage plasticity, neuroendocrine features, visceral metastases and poor prognosis. Accurately diagnosing NEPC remains difficult due to its histologic and molecular complexity but has high clinical relevance. In this study, we developed a deep learning model that leverages interpretable cellular features to improve feature extraction from H&E-stained tissue sections (NEURAL-PC). By incorporating a multiple instance learning (MIL) framework, NEURAL-PC enables robust NEPC classification solely from H&E tumor images, achieving an area under the receiver operating characteristic curve (AUROC) of 0.921 in independent external validation. In addition to its diagnostic utility, NEURAL-PC provides prognostic information that enables further subclassification of advanced prostate cancer across diverse datasets supporting its strong prognostic value and generalizability. Broadly, our work highlights a hybrid approach that integrates features across different domains, offering a promising strategy for developing reliable deep learning tools in pathology. Built on this framework, NEURAL-PC represents an extensively validated diagnostic and prognostic model for advanced prostate cancer.